Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|November 6, 2020
Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CTCaner Civan, Emine Goknur Isik, Duygu Has Simsek
Clinical Nuclear Medicine|October 28, 2017
Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CTEmre Demirci, Duygu Has Simsek, Levent Kabasakal, et al.
Clinical Nuclear Medicine|January 6, 2023
18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial CancerMurat Yilmaz Kiran, Duygu Has Simsek, Yasemin Sanli, et al.
Nuclear Medicine Communications|August 21, 2018
68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patientsYasemin Sanli, Oner Sanli, Duygu Has Simsek, et al.
Radiology Case Reports|September 6, 2021
A rare case of ruptured liver metastases from a laryngeal cancerInci Kizildag Yirgin, Meltem Ekenel, Duygu Has Simsek, et al.
Clinical Nuclear Medicine|June 5, 2019
Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the ParotidDuygu Has Simsek, Serkan Kuyumcu, Fulya Yaman Agaoglu, et al.
Clinical Nuclear Medicine|November 22, 2023
Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177 Lu-PSMA With No Adrenal InsufficiencyEdanur Topal, Duygu Has Simsek, Sezai Vatansever, et al.
Clinical Nuclear Medicine|February 25, 2021
177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell TumorDuygu Has Simsek, Caner Civan, Meltem Ekenel, et al.
Pageof 5